Increased fracture risk was particularly dangerous during the first two weeks after therapy, when the relative risk was seven times higher than patients in patients on a short-acting opioid.
After the initial two week period, the fracture risk associated with short-acting opioids dropped off but still remained greater than with NSAID therapy.
Read the Internal Medicine News report on short-acting opioids.
Read more on anesthesia:
–Maryland Anesthesiologist Arrested for Alleged Narcotic Distribution
–FDA Accepts Drug Application for Postsurgical Pain Management
–Blocking Receptor Might Help Control Post-Surgery Pain or Inflammation
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
